FLOW SYNTHESIS OF COMBRETASTATIN A-4

Slides:

Advertisements

Similar presentations

Systematic analysis and design of hybrid processes P. T. Mitkowski, G. Jonsson, R. Gani CAPEC Department of Chemical Engineering Technical University of.

Advertisements

P. 1 Wording Basic data Analysis Performance Flow pattern Concentration Temperature Pressure Practical reactor Diagram Actual process Ullmann 1 Ullmann.

A Green Approach to Nitrogen Heterocycles: Application to Biologically Active Compounds Name: Josephine Dimbleby Department: Chemistry Supervisor: Andy.

Effects of Varying Acidic Conditions on Ring Closure of acyliminium Ion Intermediates in the Synthesis of Aryl- substituted bicyclic lactams: Finding.

Computer aided design and analysis of hybrid processes P. T. Mitkowski, G. Jonsson, R. Gani CAPEC Department of Chemical Engineering Technical University.

Cyclic Aminal of TsDPEN: Synthesis and Use as Asymmetric Organocatalysts Rina Soni, Silvia Gosiewska, Guy Clarkson, Martin Wills * Department of Chemistry,

The oxidation of phenylethanol and two derivatives bearing increasingly electron-donating substituents indicates a trend whereby more electron-rich alcohols.

Design and Synthesis of a Variety of 3-Alkylanilines:

Acknowledgment Financial support by the CTQ /BQU ( ) and a grant, by Universidad de Alcalá (Spain) (M.C.) are gratefully acknowledged.

Effects of Mixing on Adipic Acid Crystallization Susan Philyaw, Kathryn Baker, Randal Nelson, Jessica Moffitt, Joy Sroykum and Dr. Terry Ring.

Lessons Learned from Organic Synthesis Joshua J. Nyman Howard Hughes Medical Institute Summer Scholar Research Project Mentor: Dr. Yan Zhang, Department.

Iron-Catalyzed Direct Arylation through an Aryl Radical Transfer Pathway Acknowledgments I would like to thank the Department of Chemistry, UNH, for funding.

AROMATIC THIOSEMICARBAZONES ARE INHIBITORS OF TRYPTOPHAN 2,3-DIOXYGENASE (TDO), AN EMERGING TARGET FOR CANCER TREATMENT Introduction and aim of the work.

1) (a) Jin, Zh. Nat. Prod. Rep. 2006, 23, 464; (b) Turner, G. L. et al, Angew. Chem. Int. Ed. 2007, 46, 7996; (c) Bagley, M. C. et al, Chem. Rev. 2005,

Isfahan University of Technology Department of Chemistry Continuous Synthesis of Diethyl Ether from Sub and Supercritical Ethanol in the Presence of Homogeneous.

Chain Extension-Mannich Reactions with Sulfonyl Imines Acknowledgments This work would not have been possible without the help of Dr. Zercher, Deepthi.

Alexander Stadler and C. Oliver Kappe* 7 th Annual High-Throughput Organic Synthesis Meeting, February 13-15, 2002, San Diego, California Institute of.

D EVELOPMENT OF A F LUORESCENT C ALCIUM (Ca 2+ ) S ENSOR TO I NVESTIGATE M ARINE S EDIMENTARY C ONDITIONS Lili Wu, Dr. Dale G. Drueckhammer.

Novel Inhibitors of Indoleamine 2,3-Dioxygenase (IDO), a Target for Anti-Cancer Immunotherapy Introduction. Immunotherapy is a promising novel strategy.

Optimization of Partial Hydrogenation Parameters Envisaged Flow Synthesis of 1 Z-Selective semi-hydrogenation of alkynes under continuous flow as part.

1 Ionic liquids—media for unique phosphorus chemistry Christopher Hardacre Chem. Commun., 2006, 72–74.

Microwave- Assisted Synthesis of 1,3- Dimesitylimidazolinium Chloride Brittney Hutchinson Department of Chemistry, University of New Hampshire, Durham,

Max Bilodeau Department of Chemistry, University of New Hampshire, Durham, NH December 1, 2013 Introduction Results and Discussion: Conclusions: Acknowledgements:

This work is supported by the FNRS and the Walloon Region (BioWin project CANTOL: Convention n° 5678). 4. References 1. Introduction 2. Synthesis and its.

METHANOL SYNTHESIS ON COPPER-BASED CATALYSTS

Neuroactive Compounds From Mollusk-Associated Bacteria Zhenjian Lin 1, Ma. Diarey B. Tianero 1,2, Rowena Antemano 1,2, Olivier Peraud 1, Margo Haygood.

(Nb-O) (Nb=O) 570 (m) 942 (s) 919 (s) (Te-O) 644 (s) (V=O) [VO 3 ] n n- 944 (s) 900 (sh) n (Mo=O) Mo 8 O (sh) (Mo=O) Mo 7 O (s) 893.

7. Catalyst BS evaluation of reducing conditions 6. Standard conditions were established using catalyst BS References and Acknowledgments.

New Developments in Pd(II)-Catalysed Cyclisations of Aminoalkenitols Dr. Peter Szolcsányi Department of Organic Chemistry Slovak University of Technology.

Progress Towards the Synthesis of 4,5-Benzoxepin Derivatives for Use in Coupling Reactions Bryanna Dowcett, Arthur Greenberg, Holly Guevara

Synthesis of New Scaffolds via Bisalkyne Cyclizations Catalyzed by Triflic Acid Jaime Alvarez Duque, Kyle Strom, John K. Snyder Boston University, Department.

Dr. Lamia Wagdy Mohamed Associate Professor of Pharmaceutical Organic Chemistry Faculty of Pharmacy- Cairo University.

Tryptophan catabolism mediated by indoleamine 2,3-dioxygenase 1 (IDO1) is an important mechanism of peripheral immune tolerance contributing to tumoural.

UNH Chemistry 756: Synthesis of 5,12-bis(phenylethynyl)-tetracene (BPEN) Acknowledgments Thanks to the UNH Chemistry Department for providing funding for.

Progress towards the Synthesis of 1-Benzoxepin; A Model Oxepin Substrate Ian Smith, Ryan Fitzgerald, Holly Guevara, Arthur Greenberg

O In Scheme 1, the first 4 steps have been carried out, resulting in the synthesis of Structure 4. o So far, high percent yields suggest that Scheme 1.

Bijay Bhattarai Faculty Advisor Debra D. Dolliver Kevin Shaughnessy University of Louisiana System Academic Summit /13/2013 SUZUKI COUPLING OF N-ALKOXYIMIDOYL.

Towards the Synthesis of Pt(IV) Analogs of Oxaliplatin Anyu Gao, Lea Nyiranshuti and Dr. Roy Planalp Parsons Hall, 23 Academic.

Reaction Pathways The goal being to synthesize FeL 2 HCl, there are many pathways that can be taken. The figure below represents the various attempts that.

Medicinal Chemistry Lecture – I Introduction and Course Overview Joseph O. Oweta B. Pharm (MUST)

6 th J-NOST CONFERENCE DATE: VENUE: DST Auditorium UNIVERSITY OF HYDERABAD DATE: VENUE: DST Auditorium UNIVERSITY OF HYDERABAD DISCOVERY.

of novel 1,2,3-triazolyl appended L-ascorbic acid derivatives

Results and Discussion

Sean Pierre-Louis, Marc Boudreau, Bill Butler

HYDROGENATION OF SOME ALKENES WITH NEW N-ACYL BENZOTRIAZOLE-Rh(I) COMPLEX IN IONIC LIQUID MEDIA Hakan ÜNVER1*, Filiz YILMAZ1 1Department of Chemistry,

Results and discussion

Isolation of the Desired Product (III)

University of New Hampshire, Department of Chemistry

Aaron Chung, Sarah Joiner

Development of New Arsenic Based Amidation Catalysts

Joey Mancinelli, Zane Relethford, Roy Planalp

Aaron Chung, Sarah Joiner

Synthesis and Photocatalysis with Cobaloxime Derivative

Envisaged Flow Synthesis of (1)

Investigation of the Effect of Ligands on Metal-to-Ligand Charge Transfer Transitions using d10-complexes of Group 11 Elements Evangelos Rossis, Roy Planalp,

Reactor Technology Research Group University of KwaZulu-Natal

ENVISAGED CONTINUOUS FLOW SYNTHESIS OF COMBRETASTATIN A-4

from Water Katherine Dombroski, Dejun Dong, Hannah Coco

Jennifer Chouinard, Prof. Erik Berda

Concentration and Solubility

Controlled Synthesis of Single-chain Nanoparticles Under Various Atom Transfer Radical Coupling Conditions Courtney M. Leo, Ashley Hanlon, Elizabeth Bright,

Results and Discussion:

Discussion and Conclusion

Envisaged Flow Synthesis of 1

CONCLUSIONS AND FUTURE DIRECTIONS

Joey Mancinelli, Justin Cole, Erik Berda

Synthesis and Characterization of a

Yields from Varying Lab Sections Summary and Conclusions

Palladium and Gold Dual Catalysis

3. Docking, physicochemistry and in vivo properties

Presentation transcript:

FLOW SYNTHESIS OF COMBRETASTATIN A-4 Ines Cazin, Laurent De Backer, Stéphane Collin, Titouan Desrues, Eduard Dolušić, Steve Lanners* Laboratoire de Chimie Organique de Synthèse, Department of Chemistry and Namur Medicine & Drug Innovation Center (Namedic), 61 rue de Bruxelles, 5000 Namur, Belgium ines.cazin@ymail.com, steve.lanners@unamur.be Introduction Introduction Combretastatin A-4 (1) is a natural product isolated from the South African bushwillow tree Combretum caffrum and endowed with a powerful inhibitory activity on microtubule formation as well as a related antiangiogenic activity.1 As such, 1 has a strong potential in anticancer therapy. A lot of effort has been done on the development of new derivatives of this compound, in order to improve the properties such as solubility and stability, and to understand the structure-activity relationships around this series.2 Synthesis of terminal alkyne Envisaged Flow Synthesis of (1) The synthesis of active pharmaceutical ingredients (API) using only flow chemistry has been pioneered by S.V. Ley et. al. in 2010.3 In order to further illustrate the feasibility of this strategy, we have devised a synthetic route for 1 which only relies on flow chemistry (Scheme 1). flow rate [µL/min] temperature [ºC] pressure [bar] reactor material base residence time [min] conversion 100 6.6 inox KtOBu 50 60 % 45 % 20 3.2 plastic 49 % 166 21 4.0 30 46 % 26 4.9 55 % 27 4.7 57 % 40 51 % 200 25 44 % 500 10 39 % 167 4.3 NaOMe 12 % 4.2 38 % 16 % 24 6.5 18 % 17 % 37 % Flow conditions: A solution of 2 (0.07 M), 3 (0.06 M) in MeOH, and base (0.12 M) in MeOH. a Conversion is based on 1H NMR analysis of crude materials. Synthesis of arylalkynes entry Ar - X R catalystc commentaryd 1a - a small amount of product 2a mostly starting materials 3b Pd(PPh3)2Cl2 53 % 4b 18 % entry Ar - X R catalystc commentaryd 1a,e - 22 % 2b 4 % 3b,e Pd(PPh3)2Cl2 63 % 4b impure product Reaction conditions: A solution ofaalkyne (1.2 M), Ar - X (1 M), base (1.1 M) and balkyne(0.6 M), Ar - X (0.5 M), base (0.55 M) in DMF was injected from pump at 0.167 mL/min. c 0.50 mol % Pd(PPh3)2Cl2 was added. The palladium catalyst and leached trace amount of copper were removed with QuadropureTM 50, 400-600 µm. d Isolated yields after chromatography on silica gel. Reaction conditions: A solution of a alkyne (1.2 M), Ar - X (1 M), base (1.1 M) and balkyne(0.6 M), Ar - X (0.5 M), base (0.55 M) in DMF was injected from pump at 0.167 mL/min.c0.50 mol % Pd(PPh3)2Cl2 was added. The palladium catalyst and leached trace amount of copper were removed with QP-TU, 400-600 µm. d Conversion is based on 1H NMR analysis of crude materials. e Reactor blocked, reaction terminated prematurely. Hydrogenation entrya Ar - X R catalystc commentaryd 1 Pd(PPh3)2Cl2 25 % 2 only starting materials 3 concentration (mg/mL) catalyst commentary 12.4 Pd/CaCO3/Pb product Pd/BaSO4/quinoline - Scheme 1. Proposed flow synthesis of Combretastatin A-4 a Reaction conditions: A solution of 7 (1.2 M), 5 (1 M), 8 (1.1 M) in DMF were mixed through pumps into a T-mixer at a total flow rate of 0.167 mL/min. b Conversion is based on 1H NMR analysis of crude materials. Figure 1. ThalesNano H-Cube® Conclusion Our idea was to integrate all of the steps of this synthetic sequence in a continuous flow operation, whereby the experimental details such as the choice of the solvent and purification of the products are of utmost importance. Once we discovered the synthetic route, we will be able to systematically optimize and improve it. We have been investigating reactions of Bestmann-Ohira and Sonogashira using Vapourtec (R- and modern E-series) machines. The final step was catalytic hydrogenation, which was conducted in the H-Cube unit from ThalesNano (Figure 1). References and Acknowledgment 1. a) Lin, C. M., et al, Mol. Pharmacol. 1988, 34, 200; b) Holt, H., et al, Top. Heterocycl. Chem. 2006, 11, 465; c) Kerr, D. J., et al, Bioorg. Med. Chem. 2007, 15, 3290. 2. a) Marrelli, M., et al, Curr. Med. Chem. 2011, 18, 3035; b) Shan, Y., et al, Curr. Med. Chem. 2011, 18, 523; c) Spatafora, C., et al, Anticancer Agents Med. Chem. 2012, 12, 902; d) Mikstacka, R., et al, Cell.Mol. Biol. Lett. 2013, 18, 368. 3. Hopkin, M. D., et al, Chem. Comm. 2010, 2450. This work is supported by WBGREEN – MICROECO (Convention No. 1217714).